When I see a product we helped develop appearing in a customers daily skincare routine, I know we have achieved the real goal of manufacturing: transforming an idea into something meaningful and reliable for consumers
Stay tuned for the 3rd part in our series: : "Dentists Weigh In: Protecting Your Smile on GLP-1 Meds" to learn exactly what the experts recommend.
GLP-1 carries most of the appetite effect, glucagon drives much of the liver- and visceral-fat loss, and GIP improves insulin handling while buffering some GLP-1-related nausea
Ru J, Li P, Wang J, Zhou W, Li B, Huang C, et al
Eli Lilly joins up with Camurus to make long-acting versions of the pharmas obesity and diabetes drugs, joining the industrys growing pipeline of programs that are differentiated by the frequency of dosing